Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

BACKGROUND: Lung cancer is a leading cause of cancer-related death in Germany and worldwide. Non-small cell lung cancer (NSCLC) comprises ~80% of lung cancer diagnoses; in White patients, around 10% of NSCLC cases are epidermal growth factor receptor mutation-positive (EGFRm+). Head-to-head clinical...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Med Oncol
Main Authors: Brückl, Wolfgang M., Reck, Martin, Griesinger, Frank, Schäfer, Harald, Kortsik, Cornelius, Gaska, Tobias, Rawluk, Justyna, Krüger, Stefan, Kokowski, Konrad, Budweiser, Stephan, Ficker, Joachim H., Hoffmann, Christopher, Schüler, Andrea, Laack, Eckart
Format: Artigo
Language:Inglês
Published: SAGE Publications 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111535/
https://ncbi.nlm.nih.gov/pubmed/33995597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211012361
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items